Steenbergen Rineke, Nanowski Terry S, Nelson Randy, Young Stephen G, Vance Jean E
Canadian Institutes for Health Research Group on the Molecular and Cell Biology of Lipids and Department of Medicine, University of Alberta, 328 HMRC, Edmonton, Alberta, Canada T6G 2S2.
Biochim Biophys Acta. 2006 Mar;1761(3):313-23. doi: 10.1016/j.bbalip.2006.03.005. Epub 2006 Mar 31.
Phosphatidylserine (PS) is synthesized in mammalian cells by two distinct serine-exchange enzymes, phosphatidylserine synthase-1 and -2. We recently demonstrated that mice lacking PS synthase-2 develop normally and exhibit no overt abnormalities [Bergo et al., (2002) J. Biol. Chem. 277:47701-47708]. We now show that PS synthase-2 mRNA levels are up to 80-fold higher in livers of embryos than in adults. Despite reduced serine-exchange activity in several tissues of PS synthase-2 deficient mice, the phospholipid composition of mitochondria and microsomes from these tissues is normal. Although PS synthase-2 is highly expressed in neurons, axon extension of cultured sympathetic neurons is not impaired by PS synthase-2 deficiency. We hypothesized that mice compensate for PS synthase-2 deficiency by modifying their phospholipid metabolism. Our data show that the rate of PS synthesis in hepatocytes is not reduced by PS synthase-2 deficiency but PS synthase-1 activity is increased. Moreover, PS degradation is decreased by PS synthase-2 deficiency, probably as a result of decreased PS degradation via phospholipases rather than decreased PS decarboxylation. These experiments underscore the idea that cellular phospholipid composition is tightly controlled and show that PS synthase-2-deficient hepatocytes modify phospholipid metabolism by several compensatory mechanisms to maintain phospholipid homeostasis.
磷脂酰丝氨酸(PS)在哺乳动物细胞中由两种不同的丝氨酸交换酶——磷脂酰丝氨酸合酶-1和-2合成。我们最近证明,缺乏PS合酶-2的小鼠发育正常,没有明显异常[贝戈等人,(2002年)《生物化学杂志》277:47701 - 47708]。我们现在表明,胚胎肝脏中PS合酶-2的mRNA水平比成年肝脏中高80倍。尽管PS合酶-2缺陷小鼠的多个组织中丝氨酸交换活性降低,但这些组织中线粒体和微粒体的磷脂组成正常。虽然PS合酶-2在神经元中高度表达,但PS合酶-2缺陷并不损害培养的交感神经元的轴突延伸。我们推测小鼠通过改变其磷脂代谢来补偿PS合酶-2的缺陷。我们的数据表明,PS合酶-2缺陷不会降低肝细胞中PS的合成速率,但PS合酶-1的活性会增加。此外,PS合酶-2缺陷会降低PS的降解,这可能是由于通过磷脂酶的PS降解减少,而不是PS脱羧减少所致。这些实验强调了细胞磷脂组成受到严格控制的观点,并表明PS合酶-2缺陷的肝细胞通过多种补偿机制改变磷脂代谢以维持磷脂稳态。